Matches in Wikidata for { <http://www.wikidata.org/entity/Q91030054> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q91030054 description "article scientifique publié en 2019" @default.
- Q91030054 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91030054 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91030054 description "scientific article published on 26 October 2019" @default.
- Q91030054 description "wetenschappelijk artikel" @default.
- Q91030054 description "наукова стаття, опублікована 26 жовтня 2019" @default.
- Q91030054 description "գիտական հոդված հրատարակված 2019 թվականի հոկտեմբերի 26-ին" @default.
- Q91030054 name "Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers" @default.
- Q91030054 name "Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers" @default.
- Q91030054 type Item @default.
- Q91030054 label "Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers" @default.
- Q91030054 label "Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers" @default.
- Q91030054 prefLabel "Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers" @default.
- Q91030054 prefLabel "Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers" @default.
- Q91030054 P1433 Q91030054-985AC063-DA44-48D4-ACE5-9BF879367665 @default.
- Q91030054 P1476 Q91030054-0E055058-CABE-41FF-BB41-7963817BFD05 @default.
- Q91030054 P2093 Q91030054-4BD16695-6A93-4FC8-A1D9-2BF84E965468 @default.
- Q91030054 P304 Q91030054-16D53B74-B736-4750-BF48-E243F5B6D3F1 @default.
- Q91030054 P31 Q91030054-0D61091F-F46A-423D-A521-830D722D0762 @default.
- Q91030054 P31 Q91030054-c5805288-c30b-48d7-ae8c-bce5a5656cc0 @default.
- Q91030054 P356 Q91030054-B95AFA6D-9224-48E9-A0AA-93A11E69625C @default.
- Q91030054 P478 Q91030054-31562C12-799F-44D8-8DBE-520EFC231653 @default.
- Q91030054 P577 Q91030054-5520E06E-71D8-434E-A160-773F7C56F1E7 @default.
- Q91030054 P698 Q91030054-8210AD4B-99AF-41EF-AB7A-0F1770FF0963 @default.
- Q91030054 P921 Q91030054-AE11DAD9-1F8A-4519-B26F-32C42E7B04BE @default.
- Q91030054 P356 J.INTIMP.2019.105967 @default.
- Q91030054 P698 31670091 @default.
- Q91030054 P1433 Q15751306 @default.
- Q91030054 P1476 "Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers" @default.
- Q91030054 P2093 "Christian Bailly" @default.
- Q91030054 P304 "105967" @default.
- Q91030054 P31 Q13442814 @default.
- Q91030054 P31 Q7318358 @default.
- Q91030054 P356 "10.1016/J.INTIMP.2019.105967" @default.
- Q91030054 P478 "77" @default.
- Q91030054 P577 "2019-10-26T00:00:00Z" @default.
- Q91030054 P698 "31670091" @default.
- Q91030054 P921 Q335099 @default.